Press release
Digital Diabetes Management Market Will Grow at a CAGR of 23.8% - Medtronic (Ireland), B.Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US)
The Digital Diabetes Management Market research report provides region-wise and country-wise analysis of the Digital Diabetes Management Market. In addition, it provides an analysis of the developing 20 countries across the globe. The region-wise study of the market includes regions such as North America, Asia Pacific, Latin America, Middle East, Africa, and Europe. It helps stakeholders understand market players and analyze the top 25 organizations based on their product footprint, market strength, and market rank. It will help stakeholders understand the market positioning of these key players.The Digital Diabetes Management Market research report segment the market comprehensively and provides the closest approximation of the market size for all subsegments across various regions. The Digital Diabetes Management Market research report offers data on key drivers, challenges, drivers, and opportunities for market growth. It also provides data about the competitive landscape section that includes product launches, expansions, collaboration, competitor ecosystem, and deals of the key players.
Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=1879016
The digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%.
Prominent players in the global digital diabetes management market are
Medtronic (Ireland),
B.Braun (Germany),
Dexcom (US),
Abbott Laboratories (US),
Roche Diagnostics (Switzerland),
Insulet Corporation (US),
Tandem Diabetes Care (US),
Ascensia Diabetes Care (Switzerland),
LifeScan (US),
Tidepool (US),
AgaMatrix (US),
Glooko Inc. (US),
and DarioHealth (Israel).
Factors such as the rising prevalence of diabetes, growing adoption of cloud-based enterprise solutions for diabetes management, increasing penetration of digital platforms and adoption of mobile apps for diabetes management, and technological advancements are driving the growth of the digital diabetes management market. However, high device costs and lack of reimbursement in developing countries and the higher acceptance of traditional diabetes management devices are expected to restrain market growth to a certain extent during the forecast period.
“Apps segment to witness the highest growth during the forecast period.”
On the basis of product& service, the digital diabetes management market is segmented into devices, apps, data management software & platforms, and services. The apps segment is expected to register the highest CAGR during the forecast period. The high acceptance of mobile apps for remote monitoring is the major factor driving the growth of this market segment.
“Self/home healthcare end-user segment to register the highest CAGR during the forecast period.”
On the basis of end user, the digital diabetes management market is segmented into self/home healthcare, hospitals & specialty diabetes clinics, and academic & research institutes. The self/home healthcare segment is expected to witness the highest CAGR owing to the launch of advanced diabetes management devices for self/home care and the shift of diabetes management from clinical settings to home care, self-administration, and remote monitoring.
“North America is projected to witness the highest growth during the forecast period.”
North America is expected to witness the highest CAGR during the forecast period, owing to the high adoption of connected diabetes management devices and apps, growing demand for technologically advanced solutions such as closed-loop systems, high adoption of remote online coaching services for diabetes management, favorable reimbursement policies, increased acceptance of digital diabetes solutions from payers, rising awareness on self-diabetes management, and government initiatives to promote digital health.
A breakdown of the primary participants referred to for this report is provided below:
By Company Type: Tier 1–46%, Tier 2–33%, and Tier 3–21%
By Designation: C-level–43%, Director Level–35%, and Others–22%
By Region: North America–34%, Europe–26%, Asia Pacific–19%, Latin America–11%,and the Middle East & Africa–10%
Research Coverage:
The report analyzes the market for various digital diabetes management products and their adoption pattern. It aims at estimating the market size and future growth potential of the global digital diabetes management market and different segments such as product & service, device type, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening their market presence.
This report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global digital diabetes management market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global digital diabetes management market
Market Development: Comprehensive information on the lucrative emerging regions by product& service, device type, end-user, and region
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global digital diabetes management market
Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global digital diabetes management market
You can Buy This Report Here: https://www.reportsnreports.com/purchase.aspx?name=1879016
Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Digital Diabetes Management Market Will Grow at a CAGR of 23.8% - Medtronic (Ireland), B.Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US) here
News-ID: 2550957 • Views: …
More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…

5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…

Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…

Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Diabetes
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027.
Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…